Alharbi, Naif Khalaf
Qasim, Ibrahim
Almasoud, Abdulrahman
Aljami, Haya A.
Alenazi, Mohamed W.
Alhafufi, Ali
Aldibasi, Omar S.
Hashem, Anwar M. http://orcid.org/0000-0002-8471-7011
Kasem, Samy
Albrahim, Raed
Aldubaib, Musaad
Almansour, Ali
Temperton, Nigel J. http://orcid.org/0000-0002-7978-3815
Kupke, Alexandra
Becker, Stephan
Abu-obaidah, Ali
Alkarar, Ali
Yoon, In-Kyu
Azhar, Esam
Lambe, Teresa
Bayoumi, Faisal
Aldowerij, Ali
Ibrahim, Osman H.
Gilbert, Sarah C. http://orcid.org/0000-0002-6823-9750
Balkhy, Hanan H.
Article History
Received: 22 July 2019
Accepted: 16 October 2019
First Online: 8 November 2019
Competing interests
: SCG is a co-founder of and consultant to Vaccitech, a spin-out company from the University of Oxford which has commercial rights to ChAdOx1 MERS. ChAdOx1 MERS vaccine is registered as an IP, number: WO 2018/215766. The remaining authors declare no potential conflict of interest.